Neomatrix Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Neomatrix Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns (NCT06814717) | Neomatrix Therapeutics, Inc. | 2025-05-12 |
| Phase 1 Healthy Volunteer Burn Therapy Study (NCT06223009) | Neomatrix Therapeutics, Inc. | 2024-01-30 |
Track Neomatrix Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.